Dr. Alexandru Barboi, MD
Claim this profileNorth Shore University HealthSystem
Studies Rapid Heartbeat
Studies Syndrome
1 reported clinical trial
1 drug studied
Affiliated Hospitals
More about Alexandru Barboi, MD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Alexandru Barboi, MD has experience with
- Efgartigimod
Breakdown of trials Alexandru Barboi, MD has run
Rapid Heartbeat
Postural Orthostatic Tachycardia Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexandru Barboi, MD specialize in?
Alexandru Barboi, MD focuses on Rapid Heartbeat and Syndrome. In particular, much of their work with Rapid Heartbeat has involved treating patients, or patients who are undergoing treatment.
Is Alexandru Barboi, MD currently recruiting for clinical trials?
No, Alexandru Barboi, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Alexandru Barboi, MD has studied deeply?
Yes, Alexandru Barboi, MD has studied treatments such as Efgartigimod.
What is the best way to schedule an appointment with Alexandru Barboi, MD?
Apply for one of the trials that Alexandru Barboi, MD is conducting.
What is the office address of Alexandru Barboi, MD?
The office of Alexandru Barboi, MD is located at: North Shore University HealthSystem, Glenview, Illinois 60026 United States. This is the address for their practice at the North Shore University HealthSystem.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.